A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber
Clinical trial NCT00420082 · COMPLETED
Trial details
- NCT number
- NCT00420082
- Sponsor
- Faes Farma, S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.